| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Analyzing the dynamics of meningococcal vaccinations initiatives by local government units in Poland (2017–2021) – Scope, challenges and recommendations
|
Świtalski, Jakub
|
|
|
42 |
15 |
p. 3461-3466
|
article
|
| 2 |
Assessment of potential adverse events following the 2022–2023 seasonal influenza vaccines among U.S. adults aged 65 years and older
|
Shi, Xiangyu Chianti
|
|
|
42 |
15 |
p. 3486-3492
|
article
|
| 3 |
A systematic review and meta-analysis on the effectiveness of bivalent mRNA booster vaccines against Omicron variants
|
Song, Shangchen
|
|
|
42 |
15 |
p. 3389-3396
|
article
|
| 4 |
Authors’ reply: Excess mortality in Cyprus during the COVID-19 vaccination campaign
|
Lytras, Theodore
|
|
|
42 |
15 |
p. 3377-3378
|
article
|
| 5 |
Avoidable COVID-19-related deaths and hospitalizations in Brazil, 2020–2023
|
Kupek, Emil
|
|
|
42 |
15 |
p. 3437-3444
|
article
|
| 6 |
BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study
|
Musa, Sanjin
|
|
|
42 |
15 |
p. 3467-3473
|
article
|
| 7 |
Collective good and individual choice: Perceptions on COVID-19 vaccine mandate among COVID-19 vaccinated individuals
|
Gudooru, Kaivalya
|
|
|
42 |
15 |
p. 3493-3498
|
article
|
| 8 |
Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations
|
van der Pol, Simon
|
|
|
42 |
15 |
p. 3429-3436
|
article
|
| 9 |
COVID-19 vaccine uptake among children and adolescents in Norway: A comprehensive registry-based cohort study of over 800,000 individuals
|
Orangzeb, Saima
|
|
|
42 |
15 |
p. 3420-3428
|
article
|
| 10 |
Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2
|
Kim, Jooyoung
|
|
|
42 |
15 |
p. 3505-3513
|
article
|
| 11 |
Determinants of uptake of influenza, zoster and pneumococcal vaccines in patients with cardiovascular diseases
|
Benedict Kpozehouen, Elizabeth
|
|
|
42 |
15 |
p. 3404-3409
|
article
|
| 12 |
Editorial Board
|
|
|
|
42 |
15 |
p. ii
|
article
|
| 13 |
Excess mortality in Cyprus during the COVID-19 vaccination campaign
|
Economidou, Eleftheria C.
|
|
|
42 |
15 |
p. 3375-3376
|
article
|
| 14 |
Identifying major histocompatibility complex class II-DR molecules in bovine and swine peripheral blood monocyte-derived macrophages using mAb-L243
|
Celis-Giraldo, Carmen
|
|
|
42 |
15 |
p. 3445-3454
|
article
|
| 15 |
Immunogenicity and protective efficacy of a multivalent herpesvirus vectored vaccine against H9N2 low pathogenic avian influenza in chicken
|
Ingrao, Fiona
|
|
|
42 |
15 |
p. 3410-3419
|
article
|
| 16 |
Immunogenicity and safety of a recombinant Omicron BA.4/5-Delta COVID-19 vaccine ZF2202-A in Chinese adults
|
Hu, Hua
|
|
|
42 |
15 |
p. 3522-3528
|
article
|
| 17 |
Low vaccine coverage and varicella outbreaks in Brazil − 2019-2022
|
Fujita, Dennis Minoru
|
|
|
42 |
15 |
p. 3384-3388
|
article
|
| 18 |
Non-specific effects of the inactivated influenza vaccine. A test-negative study: The inactivated influenza vaccine and SARS-CoV-2 infections
|
Sellies, Anne Jasmijn
|
|
|
42 |
15 |
p. 3455-3460
|
article
|
| 19 |
Predictors of willingness to receive updated 2023–2024 COVID-19 booster vaccines among a convenience sample in Minnesota
|
Ricke, I.J.
|
|
|
42 |
15 |
p. 3499-3504
|
article
|
| 20 |
Report from the World Health Organization’s immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February–1 March 2024
|
Lambach, Philipp
|
|
|
42 |
15 |
p. 3379-3383
|
article
|
| 21 |
Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands by medical risk condition: A test-negative case-control study
|
Niessen, F.A.
|
|
|
42 |
15 |
p. 3397-3403
|
article
|
| 22 |
VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice
|
Trinité, Benjamin
|
|
|
42 |
15 |
p. 3474-3485
|
article
|
| 23 |
Wa-VP4* as a candidate rotavirus vaccine induced homologous and heterologous virus neutralizing antibody responses in mice, pigs, and cynomolgus monkeys
|
Luo, Guoxing
|
|
|
42 |
15 |
p. 3514-3521
|
article
|
Journal description